清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Clinical characterisation of contact lens discomfort progression

医学 隐形眼镜 希默试验 眼科 干燥 裂隙灯 人造眼泪 干眼症 外科
作者
Laura Valencia‐Nieto,Alberto López‐de la Rosa,Alberto López‐Miguel,María J. González‐García
出处
期刊:Contact Lens and Anterior Eye [Elsevier]
卷期号:47 (1): 102096-102096
标识
DOI:10.1016/j.clae.2023.102096
摘要

Abstract

Purpose

This study aimed to assess the subjective and objective differences among the steps of the contact lens discomfort (CLD) progression classification established by the Tear Film & Ocular Surface Society (TFOS) using questionnaires and clinical signs, and to propose a simplified classification.

Methods

Contact lens (CL) wearers were evaluated in a single visit. The Contact Lens Dry Eye Questionnaire (CLDEQ)-8, the Contact Lens Discomfort Index, and Visual Analog Scales for discomfort and dryness were administered. The non-invasive break-up time, the tear film lipid layer thickness, conjunctival hyperaemia and papillae, lid-parallel conjunctival folds, the fluorescein tear film break-up time, corneal and conjunctival staining, lid wiper epitheliopathy, and the Schirmer test were assessed. Sign and symptom scores were compared among TFOS CLD progression steps using analysis of variance or the Kruskal–Wallis H test. Steps 1 and 2 (reduced comfort), and steps 3 and 4 (reduced wearing time) of the TFOS classification were combined to obtain a simplified classification, and the same comparison was performed. A p-value ≤ 0.05 was considered statistically significant.

Results

One hundred-fifty CL wearers (97 women and 53 men) aged 34.4 ± 12.6 years were included. In the TFOS classification, there were significant differences between step 0 (no CLD) and the rest of the severity steps for the scores obtained in all questionnaires (p ≤ 0.015). All steps were differentiated (p ≤ 0.032) based on the simplified classification for all questionnaires, except steps 1 and 2 for the CLDEQ-8 and dryness VAS (p = 0.089 and p = 0.051, respectively). There were no differences (all p ≥ 0.06) between the sign scores among the steps of either classification.

Conclusion

CLD management is encouraged from its first appearance. Simplifying the phases of CLD severity may allow a more accurate classification and a better awareness of the problem by clinicians and CL wearers by using more straightforward simple messages.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
龚瑶完成签到 ,获得积分10
12秒前
vbnn完成签到 ,获得积分10
26秒前
五五完成签到 ,获得积分10
34秒前
嗡嗡嗡完成签到 ,获得积分10
39秒前
科研通AI2S应助科研通管家采纳,获得30
51秒前
bkagyin应助科研通管家采纳,获得10
51秒前
9527应助科研通管家采纳,获得10
51秒前
苗条的一一完成签到,获得积分10
1分钟前
111完成签到 ,获得积分10
1分钟前
badgerwithfisher完成签到,获得积分10
1分钟前
silence完成签到 ,获得积分10
1分钟前
peterwallace完成签到 ,获得积分0
1分钟前
qq完成签到 ,获得积分10
1分钟前
guo发布了新的文献求助10
1分钟前
张勇发布了新的文献求助10
2分钟前
9527应助科研通管家采纳,获得10
2分钟前
甘sir完成签到 ,获得积分10
3分钟前
3分钟前
miaomiao发布了新的文献求助10
3分钟前
miaomiao完成签到,获得积分20
3分钟前
Tong完成签到,获得积分0
3分钟前
瘪良科研完成签到,获得积分10
4分钟前
4分钟前
guo发布了新的文献求助10
4分钟前
qiaorankongling完成签到 ,获得积分10
4分钟前
共享精神应助guo采纳,获得10
4分钟前
冷静的尔竹完成签到,获得积分10
4分钟前
喜悦的唇彩完成签到,获得积分10
4分钟前
creep2020完成签到,获得积分10
4分钟前
一盏壶完成签到,获得积分10
4分钟前
JamesPei应助ivyjianjie采纳,获得10
5分钟前
彭于晏应助所谓采纳,获得10
5分钟前
lyj完成签到 ,获得积分0
6分钟前
6分钟前
量子星尘发布了新的文献求助10
6分钟前
纤指细轻捻完成签到 ,获得积分10
6分钟前
fx完成签到,获得积分10
6分钟前
火之高兴完成签到 ,获得积分10
6分钟前
6分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
人脑智能与人工智能 1000
King Tyrant 720
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
El poder y la palabra: prensa y poder político en las dictaduras : el régimen de Franco ante la prensa y el periodismo 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5603408
求助须知:如何正确求助?哪些是违规求助? 4688394
关于积分的说明 14853596
捐赠科研通 4691019
什么是DOI,文献DOI怎么找? 2540700
邀请新用户注册赠送积分活动 1507015
关于科研通互助平台的介绍 1471649